两种igg4相关疾病亚型中68Ga-FAPI-04和18F-FDG PET/CT显示的纤维炎症活性差异

Silu Liu, Qingqing Pan, Hongzhe Zhang, Linyi Peng, Wen Zhang, YunLu Feng, Dong Wu, Yaping Luo
{"title":"两种igg4相关疾病亚型中68Ga-FAPI-04和18F-FDG PET/CT显示的纤维炎症活性差异","authors":"Silu Liu, Qingqing Pan, Hongzhe Zhang, Linyi Peng, Wen Zhang, YunLu Feng, Dong Wu, Yaping Luo","doi":"10.2967/jnumed.124.268943","DOIUrl":null,"url":null,"abstract":"<p>IgG4-related disease (IgG4-RD) is a highly heterogeneous autoimmune disease. Recently, 2 subtypes of IgG4-RD, proliferative and fibrotic, were defined according to patients’ clinicopathologic characteristics. The purpose of this study was to determine the difference in fibroinflammatory activity shown on <sup>68</sup>Ga-FAPI-04 and <sup>18</sup>F-FDG PET/CT in the proliferative and fibrotic IgG4-RD subtypes. <strong>Methods:</strong> Thirty-seven newly diagnosed IgG4-RD patients (29 of the proliferative subtype and 8 of the fibrotic subtype) who had undergone <sup>68</sup>Ga-FAPI-04 and <sup>18</sup>F-FDG PET/CT were enrolled. SUV<sub>max</sub> and target-to-background ratio (TBR) of IgG4-RD lesions were measured. To evaluate the weight of fibroinflammatory activity, the PET index of a lesion was calculated as the quotient of SUV<sub>max</sub> or TBR of <sup>68</sup>Ga-FAPI-04 and that of <sup>18</sup>F-FDG. For the assessment of the global disease in an individual patient, the PET index was defined as the ratio of SUV<sub>mean</sub> of all involved lesions in <sup>68</sup>Ga-FAPI-04 PET/CT to that in <sup>18</sup>F-FDG. <strong>Results:</strong> The <sup>18</sup>F-FDG uptake values of the most prominent lesions in the proliferative and fibrotic subtypes were similar; however, the proliferative subtype showed significantly higher uptake of <sup>68</sup>Ga-FAPI-04 than did the fibrotic subtype (SUV<sub>max</sub>, 17.67 ± 7.46 vs. 10.93 ± 2.22, <em>P</em> = 0.005; TBR, 15.49 ± 8.23 vs. 9.25 ± 3.00, <em>P</em> = 0.015). The PET index of proliferative-subtype patients was higher than that of fibrotic-subtype patients (1.46 ± 0.41 vs. 1.14 ± 0.39, <em>P</em> = 0.039). The PET index of pancreatobiliary disease was significantly higher than that of head-and-neck disease, fibrosis or aortitis, lymph nodes, and another disease subtype (<em>P</em> &lt; 0.05). After first-line treatment, patients with a PET index of at least 1.5 had significantly shorter relapse-free survival than those with a PET index of less than 1.5 (22.0 mo vs. not reached, <em>P</em> &lt; 0.0001; hazard ratio, 13.46; 95% CI, 2.236–81.03). <strong>Conclusion:</strong> The proliferative subtype of IgG4-RD had a greater weight of fibroinflammatory activity than that of the fibrotic subtype. The PET index, a marker of the weight of fibroinflammatory activity, is predictive of relapse-free survival of IgG4-RD.</p>","PeriodicalId":22820,"journal":{"name":"The Journal of Nuclear Medicine","volume":"318 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Differences in Fibroinflammatory Activity Shown on 68Ga-FAPI-04 and 18F-FDG PET/CT in the Two Subtypes of IgG4-Related Disease\",\"authors\":\"Silu Liu, Qingqing Pan, Hongzhe Zhang, Linyi Peng, Wen Zhang, YunLu Feng, Dong Wu, Yaping Luo\",\"doi\":\"10.2967/jnumed.124.268943\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>IgG4-related disease (IgG4-RD) is a highly heterogeneous autoimmune disease. Recently, 2 subtypes of IgG4-RD, proliferative and fibrotic, were defined according to patients’ clinicopathologic characteristics. The purpose of this study was to determine the difference in fibroinflammatory activity shown on <sup>68</sup>Ga-FAPI-04 and <sup>18</sup>F-FDG PET/CT in the proliferative and fibrotic IgG4-RD subtypes. <strong>Methods:</strong> Thirty-seven newly diagnosed IgG4-RD patients (29 of the proliferative subtype and 8 of the fibrotic subtype) who had undergone <sup>68</sup>Ga-FAPI-04 and <sup>18</sup>F-FDG PET/CT were enrolled. SUV<sub>max</sub> and target-to-background ratio (TBR) of IgG4-RD lesions were measured. To evaluate the weight of fibroinflammatory activity, the PET index of a lesion was calculated as the quotient of SUV<sub>max</sub> or TBR of <sup>68</sup>Ga-FAPI-04 and that of <sup>18</sup>F-FDG. For the assessment of the global disease in an individual patient, the PET index was defined as the ratio of SUV<sub>mean</sub> of all involved lesions in <sup>68</sup>Ga-FAPI-04 PET/CT to that in <sup>18</sup>F-FDG. <strong>Results:</strong> The <sup>18</sup>F-FDG uptake values of the most prominent lesions in the proliferative and fibrotic subtypes were similar; however, the proliferative subtype showed significantly higher uptake of <sup>68</sup>Ga-FAPI-04 than did the fibrotic subtype (SUV<sub>max</sub>, 17.67 ± 7.46 vs. 10.93 ± 2.22, <em>P</em> = 0.005; TBR, 15.49 ± 8.23 vs. 9.25 ± 3.00, <em>P</em> = 0.015). The PET index of proliferative-subtype patients was higher than that of fibrotic-subtype patients (1.46 ± 0.41 vs. 1.14 ± 0.39, <em>P</em> = 0.039). The PET index of pancreatobiliary disease was significantly higher than that of head-and-neck disease, fibrosis or aortitis, lymph nodes, and another disease subtype (<em>P</em> &lt; 0.05). After first-line treatment, patients with a PET index of at least 1.5 had significantly shorter relapse-free survival than those with a PET index of less than 1.5 (22.0 mo vs. not reached, <em>P</em> &lt; 0.0001; hazard ratio, 13.46; 95% CI, 2.236–81.03). <strong>Conclusion:</strong> The proliferative subtype of IgG4-RD had a greater weight of fibroinflammatory activity than that of the fibrotic subtype. The PET index, a marker of the weight of fibroinflammatory activity, is predictive of relapse-free survival of IgG4-RD.</p>\",\"PeriodicalId\":22820,\"journal\":{\"name\":\"The Journal of Nuclear Medicine\",\"volume\":\"318 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-03-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of Nuclear Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2967/jnumed.124.268943\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Nuclear Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2967/jnumed.124.268943","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

igg4相关疾病(IgG4-RD)是一种高度异质性的自身免疫性疾病。近年来,根据患者的临床病理特点,将IgG4-RD分为增生性和纤维化两种亚型。本研究的目的是确定68Ga-FAPI-04和18F-FDG PET/CT在增殖性和纤维化性IgG4-RD亚型中纤维炎症活性的差异。方法:37例经68Ga-FAPI-04和18F-FDG PET/CT检查的新诊断IgG4-RD患者(增生性亚型29例,纤维化亚型8例)。测量IgG4-RD病变的SUVmax和靶背景比(TBR)。为了评估纤维炎症活动的权重,病灶的PET指数计算为68Ga-FAPI-04的SUVmax或TBR与18F-FDG的商。为了评估单个患者的整体疾病,PET指数被定义为68Ga-FAPI-04 PET/CT中所有受累病变的SUVmean与18F-FDG的比值。结果:增生性和纤维化亚型最显著病变的18F-FDG摄取值相似;而增生性小鼠对68Ga-FAPI-04的摄取明显高于纤维化小鼠(SUVmax, 17.67±7.46 vs 10.93±2.22,P = 0.005;TBR(15.49±8.23 vs. 9.25±3.00,P = 0.015)。增生性亚型患者的PET指数高于纤维化亚型患者(1.46±0.41∶1.14±0.39,P = 0.039)。胰胆道疾病的PET指数明显高于头颈部疾病、纤维化或大动脉炎、淋巴结和其他疾病亚型(P <;0.05)。在一线治疗后,PET指数至少为1.5的患者的无复发生存期明显短于PET指数低于1.5的患者(22.0个月vs.未达到,P <;0.0001;风险比13.46;95% ci, 2.236-81.03)。结论:IgG4-RD增生性亚型比纤维化亚型具有更大的纤维炎性活性权重。PET指数是纤维炎症活动重量的标志,可预测IgG4-RD的无复发生存。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Differences in Fibroinflammatory Activity Shown on 68Ga-FAPI-04 and 18F-FDG PET/CT in the Two Subtypes of IgG4-Related Disease

IgG4-related disease (IgG4-RD) is a highly heterogeneous autoimmune disease. Recently, 2 subtypes of IgG4-RD, proliferative and fibrotic, were defined according to patients’ clinicopathologic characteristics. The purpose of this study was to determine the difference in fibroinflammatory activity shown on 68Ga-FAPI-04 and 18F-FDG PET/CT in the proliferative and fibrotic IgG4-RD subtypes. Methods: Thirty-seven newly diagnosed IgG4-RD patients (29 of the proliferative subtype and 8 of the fibrotic subtype) who had undergone 68Ga-FAPI-04 and 18F-FDG PET/CT were enrolled. SUVmax and target-to-background ratio (TBR) of IgG4-RD lesions were measured. To evaluate the weight of fibroinflammatory activity, the PET index of a lesion was calculated as the quotient of SUVmax or TBR of 68Ga-FAPI-04 and that of 18F-FDG. For the assessment of the global disease in an individual patient, the PET index was defined as the ratio of SUVmean of all involved lesions in 68Ga-FAPI-04 PET/CT to that in 18F-FDG. Results: The 18F-FDG uptake values of the most prominent lesions in the proliferative and fibrotic subtypes were similar; however, the proliferative subtype showed significantly higher uptake of 68Ga-FAPI-04 than did the fibrotic subtype (SUVmax, 17.67 ± 7.46 vs. 10.93 ± 2.22, P = 0.005; TBR, 15.49 ± 8.23 vs. 9.25 ± 3.00, P = 0.015). The PET index of proliferative-subtype patients was higher than that of fibrotic-subtype patients (1.46 ± 0.41 vs. 1.14 ± 0.39, P = 0.039). The PET index of pancreatobiliary disease was significantly higher than that of head-and-neck disease, fibrosis or aortitis, lymph nodes, and another disease subtype (P < 0.05). After first-line treatment, patients with a PET index of at least 1.5 had significantly shorter relapse-free survival than those with a PET index of less than 1.5 (22.0 mo vs. not reached, P < 0.0001; hazard ratio, 13.46; 95% CI, 2.236–81.03). Conclusion: The proliferative subtype of IgG4-RD had a greater weight of fibroinflammatory activity than that of the fibrotic subtype. The PET index, a marker of the weight of fibroinflammatory activity, is predictive of relapse-free survival of IgG4-RD.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信